MYnd Analytics Inc (MYND):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:MYnd Analytics Inc (MYND) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9842
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MYnd Analytics Inc (MYnd Analytics), formerly CNS Response Inc, is a predictive analytics company. The company develops a decision support tool that assists physicians in the provision of personalized medication for individual patients suffering from mental health issues. It provides Psychiatric EEG Evaluation Registry (PEER) Online, a cloud-based platform that enables physicians to exchange outcome data for patients referenced to neurophysiology data gathered using a standard electroencephalogram (EEG). MYnd Analytics offers reference data and analytics tools for clinicians and researchers through the company’s psychiatric EEG evaluation registry or PEER online. It serves healthcare professionals across the US. MYnd Analytics is headquartered in Mission Viejo, California, the US.

MYnd Analytics Inc (MYND) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MYnd Analytics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MYnd Analytics Inc, Medical Devices Deals, 2012 to YTD 2018 9
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
CNS Response Raises US$0.3 Million In Venture Financing 11
Equity Offering 12
MYnd Analytics Raises USD2.1 Million in Private Placement of Common Shares 12
MYnd Analytics Raises USD8.8 Million in Public Offering of Shares 13
MYnd Analytics Raises USD0.2 Million in Private Placement of Shares 15
MYnd Analytics Raises USD0.3 Million in Priavte Placement of Shares 16
MYnd Analytics to Raise USD10 Million in Private Placement of Shares 17
MYnd Analytics Raises USD1 Million in Private Placement of Shares 18
CNS Response Completes Second Tranche Of Private Placement Of Shares For US$2 Million 19
CNS Response Completes Private Placement Of Shares For US$2 Million 20
MYnd Analytics Inc – Key Competitors 22
MYnd Analytics Inc – Key Employees 23
MYnd Analytics Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Other Significant Developments 25
Aug 22, 2018: Mynd Analytics invited to present at the 2018 military health system research symposium 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MYnd Analytics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MYnd Analytics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
MYnd Analytics Inc, Medical Devices Deals, 2012 to YTD 2018 9
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
CNS Response Raises US$0.3 Million In Venture Financing 11
MYnd Analytics Raises USD2.1 Million in Private Placement of Common Shares 12
MYnd Analytics Raises USD8.8 Million in Public Offering of Shares 13
MYnd Analytics Raises USD0.2 Million in Private Placement of Shares 15
MYnd Analytics Raises USD0.3 Million in Priavte Placement of Shares 16
MYnd Analytics to Raise USD10 Million in Private Placement of Shares 17
MYnd Analytics Raises USD1 Million in Private Placement of Shares 18
CNS Response Completes Second Tranche Of Private Placement Of Shares For US$2 Million 19
CNS Response Completes Private Placement Of Shares For US$2 Million 20
MYnd Analytics Inc, Key Competitors 22
MYnd Analytics Inc, Key Employees 23
MYnd Analytics Inc, Subsidiaries 24

List of Figures
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MYnd Analytics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MYnd Analytics Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[MYnd Analytics Inc (MYND):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Eris Lifesciences Ltd (ERIS):製薬・医療:M&Aディール及び事業提携情報
    Summary Eris Lifesciences Ltd (Eris Lifesciences) is a health care products and service provider. The company offers glimepride, telmisertan, methylcobalamin and combinations, vitamin d, rabeprazole, olmesartan, mecobalamin colecalciferol, teneligliptin, rosa canina extract, cilnidipine, atorvastati …
  • Trinidad Drilling Ltd (TDG):企業の財務・戦略的SWOT分析
    Summary Trinidad Drilling Ltd (Trinidad Drilling) is an oil and gas company that offers drilling services. The company’s services include land and barge drilling, coring and presetting, well servicing, rig design and management, rig fleet management, and technical support services. Its in-house manu …
  • Airservices Australia:企業の戦略的SWOT分析
    Airservices Australia - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Norfolk Southern Corp (NSC):企業の財務・戦略的SWOT分析
    Norfolk Southern Corp (NSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Next Fifteen Communications Group plc:企業のM&A・事業提携・投資動向
    Next Fifteen Communications Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Next Fifteen Communications Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • Mirage Retail Group BV:企業の戦略的SWOT分析
    Mirage Retail Group BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • RCS MediaGroup S.p.A. (RCS):企業の財務・戦略的SWOT分析
    RCS MediaGroup S.p.A. (RCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Pampa Energia S.A (PAMP)-石油・ガス分野:企業M&A・提携分析
    Summary Pampa Energia S.A. (Pampa) is an integrated energy company. It generates, transmits and distributes electricity. The company produces electricity from thermal, hydro and wind sources. Pampa explores for and produces hydrocarbon products in Argentina, Ecuador and Venezuela; refines diesel, fu …
  • Rev1 Ventures Inc.:企業のM&A・事業提携・投資動向
    Rev1 Ventures Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Rev1 Ventures Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • TriMedx LLC:企業の戦略的SWOT分析
    TriMedx LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Immucor, Inc.-医療機器分野:企業M&A・提携分析
    Summary Immucor, Inc. (Immucor) is an in-vitro diagnostics company, which specializes in the area of pre-transfusion diagnostics. It carries out the development, production and sale of a comprehensive line of reagents and automated systems. The company’s products are used in performing the tests to …
  • Hunt’s Foodservice Ltd:企業の戦略・SWOT・財務情報
    Hunt's Foodservice Ltd - Strategy, SWOT and Corporate Finance Report Summary Hunt's Foodservice Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Royal Orchid Hotels Ltd:企業の戦略・SWOT・財務分析
    Royal Orchid Hotels Ltd - Strategy, SWOT and Corporate Finance Report Summary Royal Orchid Hotels Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • GtreeBNT Co Ltd (115450):製薬・医療:M&Aディール及び事業提携情報
    Summary GtreeBNT Co Ltd (GtreeBNT), formerly Digital Aria, is a pharmaceutical company. The company researches and develops pharmaceutical products. It develops GBT-201 for the treatment of ophthalmologic diseases such as dry eye syndrome and neurotrophic keratopathy; and GBT-101 for treating epider …
  • PetSmart Inc:企業の戦略・SWOT・財務分析
    PetSmart Inc - Strategy, SWOT and Corporate Finance Report Summary PetSmart Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Colefax Group Plc:企業の戦略・SWOT・財務情報
    Colefax Group Plc - Strategy, SWOT and Corporate Finance Report Summary Colefax Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • The Tata Power Company Limited:企業の戦略・SWOT・財務分析
    The Tata Power Company Limited - Strategy, SWOT and Corporate Finance Report Summary The Tata Power Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • TClarke Plc (CTO):企業の財務・戦略的SWOT分析
    TClarke Plc (CTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Toppan Forms Co Ltd:企業の戦略・SWOT・財務分析
    Toppan Forms Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Toppan Forms Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • ProPhotonix Limited (PPIX):企業の財務・戦略的SWOT分析
    ProPhotonix Limited (PPIX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆